{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T11:35:21Z","timestamp":1770550521017,"version":"3.49.0"},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:p>Ipilimumab is a monoclonal antibody that exerts its effects by inhibiting the cytotoxic T-lymphocyte-associated protein 4 receptor on cytotoxic T lymphocytes. It is frequently used for the treatment of unresectable or metastatic melanoma. Ipilimumab may lead to several immune-related disease including colitis, thyroiditis, pneumonia, hepatitis, or pancreatitis as a side effect. Limited number of cases with hepatic damage as an ipilimumab-related adverse event has been reported in the literature. This agent has been implicated in causing acute hepatitis-like liver injury. Here, we presented a case in which cholestatic hepatitis developed during ipilimumab use for the treatment of metastatic melanoma.<\/jats:p>","DOI":"10.1097\/cmr.0000000000000366","type":"journal-article","created":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T14:56:17Z","timestamp":1494341777000},"page":"380-382","source":"Crossref","is-referenced-by-count":10,"title":["Ipilimumab-associated cholestatic hepatitis: a case report and literature review"],"prefix":"10.1097","volume":"27","author":[{"given":"S\u00fcmeyra","family":"Yildirim","sequence":"first","affiliation":[{"name":"Gastroenterology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kemal","family":"Deniz","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ender","family":"Do\u011fan","sequence":"additional","affiliation":[{"name":"Oncology, Erciyes University, Kayseri, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mevl\u00fct","family":"Ba\u015fkol","sequence":"additional","affiliation":[{"name":"Gastroenterology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u015eebnem","family":"G\u00fcrsoy","sequence":"additional","affiliation":[{"name":"Gastroenterology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Metin","family":"\u00d6zkan","sequence":"additional","affiliation":[{"name":"Oncology, Erciyes University, Kayseri, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230902","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1007\/s10620-012-2140-5","article-title":"Pathologic changes in ipilimumab-related hepatitis in patients with metastatic melanoma","volume":"57","author":"Kleiner","year":"2012","journal-title":"Dig Dis Sci"},{"key":"R2-20230902","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s10637-013-9939-6","article-title":"Ipilimumab associated hepatitis: imaging and clinicopathologic findings","volume":"31","author":"Kim","year":"2013","journal-title":"Invest New Drugs"},{"key":"R3-20230902","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/jgh.12888","article-title":"Ipilimumab-induced toxicities and the gastroenterologist","volume":"30","author":"Cheng","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"R4-20230902","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/PAS.0000000000000453","article-title":"Ipilimumab-associated hepatitis: clinicopathologic characterization in a series of 11 cases","volume":"39","author":"Johncilla","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R5-20230902","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/his.13082","article-title":"The histopathological evaluation of drug-induced liver injury","volume":"70","author":"Kleiner","year":"2017","journal-title":"Histopathology"}],"container-title":["Melanoma Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008390-201708000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T03:15:42Z","timestamp":1693624542000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008390-201708000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/cmr.0000000000000366","relation":{},"ISSN":["0960-8931"],"issn-type":[{"value":"0960-8931","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}